Revenue from pharma tests and services, and all other customers in the range of $62 to $64 million; Revenue from population sequencing and enterprise sales in the range of $15 to $16 million; Revenue from clinical tests reimbursed in the range of $3 to $10 million.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSNL: